Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 135

Results For "GE"

8814 News Found

USFDA approves Marinus’ treatment for genetic disorder
Drug Approval | March 19, 2022

USFDA approves Marinus’ treatment for genetic disorder

First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older


Thirty five generic manufacturers sign agreements with MPP for Paxlovid
News | March 18, 2022

Thirty five generic manufacturers sign agreements with MPP for Paxlovid

The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris


AstraZeneca launches global R&D post-doctoral challenge
News | March 18, 2022

AstraZeneca launches global R&D post-doctoral challenge

Successful proposals will secure fully funded postdoctoral research positions


11-year-old Oman girl undergoes gastro trichobezoar surgery
Hospitals | March 18, 2022

11-year-old Oman girl undergoes gastro trichobezoar surgery

Doctors at Yashoda Hospitals Hyderabad perform rare operation


Biological E gears up for new phase of vaccination drive
News | March 17, 2022

Biological E gears up for new phase of vaccination drive

To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India


IQVIA launches OCE+ to deliver AI-driven customer engagement
Digitisation | March 16, 2022

IQVIA launches OCE+ to deliver AI-driven customer engagement

OCE+ uses IQVIA’s industry-leading data and advanced analytics to deliver AI-driven recommendations directly into the daily workflows of life sciences commercial teams


UFDA approves first generic of Symbicort to treat asthma and COPD
Drug Approval | March 16, 2022

UFDA approves first generic of Symbicort to treat asthma and COPD

This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)


Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates
Biotech | March 16, 2022

Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates

Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer


Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments
News | March 15, 2022

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023


Uniphore and SpinSci join hands to improve patient access and engagement
Digitisation | March 15, 2022

Uniphore and SpinSci join hands to improve patient access and engagement

Deploying solutions like Uniphore’s U-Self Serve and U-Assist with SpinSci’s Patient Engage and Patient Assist is an important step forward in creating frictionless patient experiences